<DOC>
	<DOCNO>NCT01650077</DOCNO>
	<brief_summary>Non-interventional study consist population patient receive soft tissue sarcoma least 2 course Yondelis® dose 1.5 mg / m² / 3 week failure intolerance doxorubicin / ifosfamide 2007 2011 .</brief_summary>
	<brief_title>Therapeutic Response Patients With Soft Tissue Sarcoma According CHOI Criteria</brief_title>
	<detailed_description>Patient selection base database retrospectively within GSF / GETO . The tumor assessment must make scanner baseline post-C2 C3 available sent sponsor . The comparative reading image centralize make without knowledge local assessment : - sum large diameter 2 imagery ( baseline 1st evaluation - tumor density area interest 2 imaging ( baseline 1st evaluation - Rank patient accord two method ( Choi RECIST ) : complete response , partial response , stability , progress non-assessable .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<criteria>age ≥ 18 year locally advance metastatic soft tissue sarcoma treat Yondelis failure intolerance doxorubicin/ifosfamide treat 2007 2011 least 2 cycle Yondelis assessment tumor CT scan ( baseline 2 3 cycle Yondelis ) Gastro Intestinal Stromal Tumor GIST primitive bone sarcoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Soft tissue sarcoma</keyword>
	<keyword>Yondelis</keyword>
	<keyword>Intolerance doxorubicin/ifosfamide</keyword>
	<keyword>CHOI criterion</keyword>
</DOC>